Results of an organ conservation protocol in patients with locally advanced laryngeal tumours;Resultados de un protocolo de preservación de órgano en pacientes con tumores localmente avanzados de la laringe

Acta Otorrinolaringologica Espanola

Volumn 60, Issue 3, 2009, Pages 176-185

  León, Xavier ^a   López, Montserrat ^a   García, Jacinto ^a   Quer, Miquel ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Induction chemotherapy; Laryngeal carcinoma; Organ preservation

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DRUG FATALITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LARYNGECTOMY; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; ORGAN PRESERVATION; SURVIVAL RATE; TREATMENT RESPONSE;

AGED; CLINICAL PROTOCOLS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 67649185289     PISSN: 00016519     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-6519(09)71227-0     Document Type: Article

References (24)

1. Quer M., and León X. Modalidades de preservación de órgano en carcinomas de laringe e hipofaringe. Acta Otorrinolaringol Esp 58 (2007) 476-482
2. Mendenhall W.M. T3-4 squamous cell carcinoma of the larynx treated with radiation therapy alone. Semin Radiat Oncol 8 (1998) 262-269
3. Jorgensen K., Godballe C., Hansen O., and Bastholt L. Cancer of the larynx: treatment results after primary radiotherapy with salvage surgery in a series of 1005 patients. Acta Oncol 41 (2002) 69-76
4. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324 (1991) 1685-1690
5. Lefebvre J.L., Chevalier D., Luboinski B., Kirkpatrick A., Collette L., and Sahmoud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst 88 (1996) 890-899
6. Browman G.P., Hodson D.I., Mackenzie R.J., Bestic N., Zuraw L., and Cancer Care Ontario Practice Guideline Initiative Head and Neck Cancer Disease Site Group. Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis. Head Neck 23 (2001) 579-589
7. León X., Orús C., and Quer M. Diseño, mantenimiento y explotación de una base de datos oncológica para pacientes con tumores de cabeza y cuello. Acta Otorrinolaringol Esp 53 (2002) 185-190
8. León X., Quer M., Orús C., De Dios E., and Recher K. Treatment of neck nodes after induction chemotherapy in patients with primary advanced tumours. Eur Arch Otorhinolaryngol 257 (2000) 521-525
9. De Andrés L., Brunet J., López-Pousa A., Burgués J., Quer M., León X., et al. Function preservation in stage III squamous laryngeal carcinoma: results with an induction chemotherapy protocol. Laryngoscope 105 (1995) 822-826
10. León X., López-Pousa A., De Vega M., Orús C., De Juan M., and Quer M. Results of an organ preservation protocol with induction chemotherapy and radiotherapy in patients with locally advanced laryngeal carcinoma. Eur Arch Otorhinolaryngol 262 (2005) 93-98
11. Majem M., Mesia R., Mañós M., Gomez J., Galiana R., Cardenal F., et al. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma. Laryngoscope 116 (2006) 1651-1656
12. Urba S., Wolf G., Eisbruch A., Worden F., Lee J., Bradford C., et al. Single-cycle induction chemotherapy selecs patients with advanced laryngeal cancer for combined chemoradiation: A new treatment paradigm. J Clin Oncol 24 (2006) 593-598
13. Teknos T.N., Cox C., Barrios M.A., Chepeha D.B., Bradford C.R., Fisher S.G., et al. Tumor angiogenesis as a predictive marker for organ preservation in patients with advanced laryngeal carcinoma. Laryngoscope 112 (2002) 844-851
14. Kumar B., Cordell K.G., D'Silva N., Prince M.E., Adams M.E., Fisher S.G., et al. Expression of p53 and Bcl-xL as predictive markers for larynx preservation in advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 134 (2008) 363-369
15. Pavón M.A., Parreño M., León X., Sancho F.J., Céspedes M.V., Casanova I., et al. Ku70 predicts response and primary tumor recurrence after therapy in locally advanced head and neck cancer. Int J Cancer 123 (2008) 1068-1079
16. León X., Quer M., Orús C., López-Pousa A., Pericay C., and Vega M. How much it cost to preserve a larynx? An economic study. Eur Arch Otorhinolaryngol 257 (2000) 72-76
17. Davis G.E., Schwartz S.R., Veenstra D.L., and Yueh B. Cost comparison of surgery vs organ preservation for laryngeal cancer. Arch Otolaryngol Head Neck Surg 131 (2005) 21-26
18. Terrell J.E., Fisher S.G., and Wolf G.T. Long-term quality of life after treatment of laryngeal cancer. The Veterans Affairs Laryngeal Cancer Study Group. Arch Otolaryngol Head Neck Surg 124 (1998) 964-971
19. Boscolo-Rizzo P., Maronato F., Marchiori C., Gava A., and Da Mosto M.C. Long-term quality of life after total laryngectomy and postoperative radiotherapy versus concurrent chemoradiotherapy for laryngeal preservation. Laryngoscope 118 (2008) 300-306
20. Forastiere A.A., Goepfert H., Maor M., Pajak T.F., Weber R., Morrison W., et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349 (2003) 2091-2098
21. Venegas M.P., León X., Quer M., Matiñó E., Montoro V., and Burgués J. Complicaciones de la laringectomía total en función del uso previo de radioterapia. Acta Otorrinolaringol Esp 48 (1997) 639-646
22. Hitt R., López-Pousa A., Martínez-Trufero J., Escrig V., Carles J., Rizo A., et al. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol 23 (2005) 8636-8645
23. Posner M.R., Hershock D.M., Blajman C.R., Mickiewicz E., Winquist E., Gorbounova V., et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 357 (2007) 1705-1715
24. Bonner J.A., Harari P.M., Giralt J., Azarnia N., Shin D.M., Cohen R.B., et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354 (2006) 567-578